News & Press Releases
Filter by:
Mintz advised the underwriters in connection with Verastem Oncology’s $250 million underwritten offering of common stock and pre-funded warrants.
What Happens When the Last 401k Plan Fiduciary Disappears?
October 13, 2026
Michelle Capezza was quoted in a Fiduciary News article examining how retirement plans can be properly managed and terminated when a plan sponsor goes out of business or dissolves.
Lexie Gallo-Cook was quoted in a Law.com article about geopolitical disruptions and supply chain pressures driving legal disputes, arbitration, and antitrust litigation across global industries, including the fertilizer sector.
Mintz Advises Smartcar in Sale to Everyday Electric
October 12, 2026
Mintz advised Smartcar, a connected-vehicle platform, in its sale to Everyday Electric (formerly known as Renew Home).
Mintz Advises on Atrium Therapeutics’ $50 Million Private Placement
October 12, 2026
Mintz advised the placement agents in connection with Atrium Therapeutics’ $50 million private placement of common stock and pre-funded warrants.
Robert Vlasis’ insights were featured in an MLex article discussing whether the U.S. International Trade Commission (ITC) should continue a Section 337 trade-secret investigation involving Zync and BMW despite a forum-selection clause requiring litigation in Germany.
